News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wells David R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/22/2023 |
4
| Wells David R. (Director) has filed a Form 4 on Heart Test Laboratories, Inc.|
Txns:
| Granted 50,000 options to buy
@ $0 |
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Exercised (in-or-at-the-money) 5,000 warrants
@ $0.87, valued at
$4.4k
|
|
| 06/10/2020 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Converted 10,350 shares
@ $0.87, valued at
$9k
Converted 9 convertible preferred
@ $1143.68, valued at
$10k
|
|
| 04/13/2020 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 79,653 shares
@ $0 |
|
| 01/28/2020 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 20,000 options
@ $1.71, valued at
$34.2k
|
|
| 12/11/2019 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 138,375 options to buy
@ $0.9, valued at
$124.5k
Granted 9 convertible preferred
@ $1143.68, valued at
$10k
Granted 10,051 warrants
@ $0.87, valued at
$8.7k
|
|
| 09/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Bought 5,000 shares
@ $1.56, valued at
$7.8k
Bought 5,000 shares
@ $1.55, valued at
$7.8k
|
|
| 05/15/2019 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 56,000 options
@ $1.38, valued at
$77.3k
|
|
| 12/17/2018 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted 35,000 options
@ $2.25, valued at
$78.8k
|
|
| 11/15/2018 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Converted 5,953 shares
@ $1.68, valued at
$10k
Converted convertible notes
@ $1.68, valued at
$0 |
|
| 07/02/2018 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc.|
Txns:
| Granted convertible notes
@ $10000, valued at
$0
Granted 2,480 warrants
@ $2.52, valued at
$6.2k
|
|
| 05/16/2017 |
4
| Wells David R. (CFO) has filed a Form 4 on ENDRA Life Sciences Inc. |
| 05/04/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/07/2011 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Granted 500,000 options to buy
@ $0.1, valued at
$50k
Granted 1,000,000 options to buy
@ $0.07, valued at
$70k
Granted 1,000,000 options to buy
@ $0.09, valued at
$90k
Granted 1,000,000 options to buy
@ $0.12, valued at
$120k
Granted 1,000,000 options to buy
@ $0.15, valued at
$150k
|
|
| 01/03/2011 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Bought 20,833 shares
@ $0.048, valued at
$1000 |
|
| 12/15/2010 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Bought 22,222 shares
@ $0.045, valued at
$1000 |
|
| 12/10/2010 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Bought 16,666 shares
@ $0.06, valued at
$1000 |
|
| 12/10/2010 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Bought 15,386 shares
@ $0.065, valued at
$1k
|
|
| 11/04/2010 |
4
| Wells David R. (President, CFO) has filed a Form 4 on SIONIX CORP|
Txns:
| Gifted 25,000 shares
@ $0
Bought 18,181 shares
@ $0.548, valued at
$10k
Bought 17,181 shares
@ $0.0579, valued at
$994.8 |
|
|
|